dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T12:41:39Z
dc.date.accessioned2022-12-19T23:01:28Z
dc.date.available2021-06-25T12:41:39Z
dc.date.available2022-12-19T23:01:28Z
dc.date.created2021-06-25T12:41:39Z
dc.date.issued2021-03-01
dc.identifierAnais Brasileiros De Dermatologia. New York: Elsevier Science Inc, v. 96, n. 2, p. 240-242, 2021.
dc.identifier0365-0596
dc.identifierhttp://hdl.handle.net/11449/210165
dc.identifier10.1016/j.abd.2020.06.009
dc.identifierS0365-05962021000200240
dc.identifierWOS:000634512500020
dc.identifierS0365-05962021000200240.pdf
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5390762
dc.description.abstractSmall vessel vasculitis with anti-proteinase antibodies 3 is an atypical clinical presentation of tuberculosis. The authors present the case of a 47-year-old male patient, with palpable purpura and palmoplantar hemorrhagic blisters, with subsequent dissemination. He presented severe pulmonary symptoms with cavitation, fever, hemoptysis, and high levels of anti-proteinase 3. Histopathological assessment of the skin revealed small vessel vasculitis; pulmonary histopathology showed granulomas with caseation. Bronchoalveolar lavage was positive for alcohol-acid-fast bacilli. In countries with a high prevalence of tuberculosis, the presence of autoantibodies in a patient with vasculitis, fever, and pulmonary cavitation requires investigation of infectious causes. (C) 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana, S.L.U.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationAnais Brasileiros De Dermatologia
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectAnti-neutrophil cytoplasmic antibodies
dc.subjectAnti-neutrophil cytoplasmic antibody-associated vasculitis
dc.subjectTuberculosis
dc.subjectVasculitis
dc.titleCase for diagnosis. Cutaneous small vessel vasculitis (anti-proteinase 3 positive), fever, hemoptysis, and lung cavitation in an adult
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución